Assembly Biosciences, Inc. (ASMB) vs Capricor Therapeutics, Inc. (CAPR)
A side-by-side comparison of Assembly Biosciences, Inc. and Capricor Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ASMB
Assembly Biosciences, Inc.
$22.74HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CAPR
Capricor Therapeutics, Inc.
$7.78HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ASMB vs CAPR
growth of $100 · dividends reinvested · last 10yASMB -76.4% (-13.4%/yr)CAPR -76.9% (-13.6%/yr)ASMB compounded faster over this window
ASMB CAPR
ASMB vs CAPR: by the numbers
- •ASMB is the larger company ($451M vs $447M market cap).
Metrics side by side
Valuation
| Metric | ASMB | CAPR |
|---|---|---|
| P/E ratio | 41.35 | N/A |
| P/S ratio | 6.02 | N/A |
| P/B ratio | 1.47 | 1.82 |
| EV / EBITDA | N/A | 0.44 |
Profitability
| Metric | ASMB | CAPR |
|---|---|---|
| Gross margin | 99.82% | 0.00% |
| Operating margin | -11.75% | 0.00% |
| Net margin | -0.06% | 0.00% |
| ROE | -0.01% | -52.56% |
| ROIC | -2.86% | -40.25% |
Growth (annualized)
| Metric | ASMB | CAPR |
|---|---|---|
| Revenue CAGR (5Y) | -1.78% | N/A |
| Total return CAGR (5Y) | -10.66% | 15.17% |
Frequently asked
- How have ASMB and CAPR total returns compared?
- Over the past 10 years, ASMB delivered -13.41% and CAPR delivered -13.84% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.